CAITLIN FIELD: Open Payments
NPI 1417408279 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 49 payments from 10 companies in 2025. Trend: 2023 $131 · 2024 $1,035 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $367 |
| Regeneron Healthcare Solutions, Inc. | 3 | $179 |
| ABBVIE INC. | 26 | $171 |
| UCB, Inc. | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| GENZYME CORPORATION | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, Zoryve, TALTZ, OTEZLA.
Industry payments across LA — which companies pay providers there.
